Literature DB >> 26856840

Antimicrobial Resistance in Salmonella in the United States from 1948 to 1995.

Daniel A Tadesse1, Aparna Singh2, Shaohua Zhao1, Mary Bartholomew3, Niketta Womack1, Sherry Ayers1, Patricia I Fields4, Patrick F McDermott5.   

Abstract

We conducted a retrospective study of 2,149 clinicalSalmonellastrains to help document the historical emergence of antimicrobial resistance. There were significant increases in resistance to older drugs, including ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline, which were most common inSalmonella entericaserotype Typhimurium. An increase in multidrug resistance was observed for each decade since the 1950s. These data help show howSalmonellaevolved over the past 6 decades, after the introduction of new antimicrobial agents.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26856840      PMCID： PMC4808194          DOI： 10.1128/AAC.02536-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Resistance to trimethoprim and sulfonamides.

Authors:  O Sköld
Journal:  Vet Res       Date:  2001 May-Aug       Impact factor: 3.683

2.  Increase in resistance to ceftriaxone and nonsusceptibility to ciprofloxacin and decrease in multidrug resistance among Salmonella strains, United States, 1996-2009.

Authors:  Felicita Medalla; Robert M Hoekstra; Jean M Whichard; Ezra J Barzilay; Tom M Chiller; Kevin Joyce; Regan Rickert; Amy Krueger; Andrew Stuart; Patricia M Griffin
Journal:  Foodborne Pathog Dis       Date:  2013-03-06       Impact factor: 3.171

3.  Morbidity of infections caused by antimicrobial-resistant bacteria.

Authors:  Karin Travers; Michael Barza
Journal:  Clin Infect Dis       Date:  2002-06-01       Impact factor: 9.079

Review 4.  Nontyphoidal salmonellosis.

Authors:  E L Hohmann
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

5.  Characterization of Salmonella enterica serotype newport isolated from humans and food animals.

Authors:  S Zhao; S Qaiyumi; S Friedman; R Singh; S L Foley; D G White; P F McDermott; T Donkar; C Bolin; S Munro; E J Baron; R D Walker
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

6.  Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium.

Authors:  Morten Helms; Pernille Vastrup; Peter Gerner-Smidt; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

7.  Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995.

Authors:  Efrain M Ribot; Rachel K Wierzba; Frederick J Angulo; Timothy J Barrett
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

8.  Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States.

Authors:  Amita Gupta; John Fontana; Colleen Crowe; Barbara Bolstorff; Alison Stout; Susan Van Duyne; Mike P Hoekstra; Jean M Whichard; Timothy J Barrett; Frederick J Angulo
Journal:  J Infect Dis       Date:  2003-11-18       Impact factor: 5.226

9.  Outbreak of multidrug-resistant Salmonella newport--United States, January-April 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-06-28       Impact factor: 17.586

10.  Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998.

Authors:  Therese Rabatsky-Ehr; Jean Whichard; Shannon Rossiter; Ben Holland; Karen Stamey; Marcia L Headrick; Timothy J Barrett; Frederick J Angulo
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883
View more
  5 in total

1.  Interplay of cold shock protein E with an uncharacterized protein, YciF, lowers porin expression and enhances bile resistance in Salmonella Typhimurium.

Authors:  Semanti Ray; Rochelle Da Costa; Mrinmoy Das; Dipankar Nandi
Journal:  J Biol Chem       Date:  2019-04-16       Impact factor: 5.157

2.  In Vitro Susceptibility of Typhoidal, Nontyphoidal, and Extended-Spectrum-β-Lactamase-Producing Salmonella to Ceftolozane/Tazobactam.

Authors:  Jade L L Teng; Elaine Chan; Asher C H Dai; Gillian Ng; Tsz Tuen Li; Christopher Lai; Alan K L Wu; Susanna K P Lau; Patrick C Y Woo
Journal:  Antimicrob Agents Chemother       Date:  2021-10-18       Impact factor: 5.938

3.  Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection.

Authors:  Bruce McCollister; Cassandra V Kotter; Daniel N Frank; Taylor Washburn; Michael G Jobling
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Transmissible ST3-IncHI2 Plasmids Are Predominant Carriers of Diverse Complex IS26-Class 1 Integron Arrangements in Multidrug-Resistant Salmonella.

Authors:  Hang Zhao; Wenyao Chen; Xuebin Xu; Xiujuan Zhou; Chunlei Shi
Journal:  Front Microbiol       Date:  2018-10-23       Impact factor: 5.640

5.  Distribution of Antimicrobial Resistance Genes across Salmonella enterica Isolates from Animal and Nonanimal Foods.

Authors:  J B Pettengill; H Tate; K Gensheimer; C H Hsu; J Ihrie; A O Markon; P F McDERMOTT; S Zhao; E Strain; M C Bazaco
Journal:  J Food Prot       Date:  2020-01-21       Impact factor: 2.745
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.